<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>A partial nontandem duplication (PNTD) of mixed lineage <z:hpo ids='HP_0001909'>leukemia</z:hpo> (MLL) gene is described in B-cell <z:hpo ids='HP_0006721'>acute lymphoid leukemia</z:hpo> without structural cytogenetic abnormalities at 11q23 and 9p22 </plain></SENT>
<SENT sid="1" pm="."><plain>A duplicated portion of MLL is interrupted by the insertion of a region of 9p22 that includes the 3'-end of the AF9 gene </plain></SENT>
<SENT sid="2" pm="."><plain>The PNTD encodes: (a) a PNTD transcript; (b) a partial tandem duplication of MLL; and (c) a chimeric transcript fusing MLL to the 3'-end of AF9, mimicking the t(9;11)(p22;q23) and expressed 1024-fold higher than the other two </plain></SENT>
<SENT sid="3" pm="."><plain>The MLL PNTD, therefore, contributes toward <z:e sem="disease" ids="C0598766" disease_type="Neoplastic Process" abbrv="">leukemogenesis</z:e> through simultaneous production of fusion transcripts that are otherwise encoded by three distinct genetic defects </plain></SENT>
</text></document>